Compare ARBE & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARBE | RFL |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Real Estate |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 63.5M |
| IPO Year | N/A | 2017 |
| Metric | ARBE | RFL |
|---|---|---|
| Price | $0.76 | $1.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.38 | N/A |
| AVG Volume (30 Days) | ★ 985.5K | 46.9K |
| Earning Date | 05-19-2026 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $917,000.00 |
| Revenue This Year | $363.94 | N/A |
| Revenue Next Year | $286.43 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $0.55 | $1.12 |
| 52 Week High | $2.88 | $3.19 |
| Indicator | ARBE | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 58.70 |
| Support Level | $0.76 | $1.30 |
| Resistance Level | $1.46 | $1.34 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 50.04 | 86.49 |
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.